Therefore, at the beginning of this century, Forrest et al. reported the first study, which combined routine objective markers of the systemic inflammatory response (CRP and ALB, termed as GPS), and showed superiority than the clinical standard combination of TNM system and ECOG PS on survivals in various cancer types [8–11]. This evidence concerns the gene ALB and cancer.